STEQEYMA® (ustekinumab-stba) is Celltrion's biosimilar to STELARA® (ustekinumab), which was launched on March 12, 2025 Celltrion's adalimumab-aaty was previously added to the Costco Member Prescription Program in August 2024 JERSEY CITY, N.J., March 27, 2025 /PRNewswire/ -- Celltrion, Inc....
Hence then, the article about celltrion s steqeyma ustekinumab stba now added to the costco member prescription program was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Celltrion's STEQEYMA® (ustekinumab-stba), now added to the Costco Member Prescription Program )
Also on site :
- In 1957, Ford launched the Edsel after spending $250 million developing it; two years later Ford discontinued it, having lost $350 million
- In 1948, William Rosenberg used $1,500 in war bonds and a $1,000 loan to open his first coffee shop; Dunkin’ Donuts later sold for $11.3 billion to Inspire Brand
- In 1889, Emile Zatarain began selling root beer from a New Orleans grocery; his family’s spice company sold to McCormick for $180 million in 2003